Abstract:Nanocarriers for delivery of phytoconstituents against lung cancer. Lung cancer, the second leading cause of cancer‐related deaths, accounts for a substantial portion, representing 18.4% of all cancer fatalities. Despite advances in treatment modalities such as chemotherapy, surgery, and immunotherapy, significant challenges persist, including chemoresistance, non‐specific targeting, and adverse effects. Consequently, there is an urgent need for innovative therapeutic approaches to overcome these limitations. Natural compounds, particularly phytoconstituents, have emerged as promising candidates due to their potent anticancer properties and relatively low incidence of adverse effects compared to conventional treatments. However, inherent challenges such as poor solubility, rapid metabolism, and enzymatic degradation hinder their clinical utility. To address these obstacles, researchers have increasingly turned to nanotechnology‐based drug delivery systems (DDS). Nanocarriers offer several advantages, including enhanced drug stability, prolonged circulation time, and targeted delivery to tumor sites, thereby minimizing off‐target effects. By encapsulating phytoconstituents within nanocarriers, researchers aim to optimize their bioavailability and therapeutic efficacy while reducing systemic toxicity. Moreover, the integration of nanotechnology with phytoconstituents allows for a nuanced understanding of the intricate molecular pathways involved in lung cancer pathogenesis. This integrated approach holds promise for modulating key cellular processes implicated in tumor growth and progression. Additionally, by leveraging the synergistic effects of phytoconstituents and nanocarriers, researchers seek to develop tailored therapeutic strategies that maximize efficacy while minimizing adverse effects. In conclusion, the integration of phytoconstituents with nanocarriers represents a promising avenue for advancing lung cancer treatment. This synergistic approach has the potential to revolutionize current therapeutic paradigms by offering targeted, efficient, and minimally toxic interventions. Continued research in this field holds the promise of improving patient outcomes and addressing unmet clinical needs in lung cancer management.

Targeting the lung tumour stroma: harnessing nanoparticles for effective therapeutic interventions

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer

Moving beyond traditional therapies: the role of nanomedicines in lung cancer

The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment

Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy

Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment

Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy

Nanotechnology for the theranostic opportunity of breast cancer lung metastasis: recent advancements and future challenges

Nanomedicine Disrupts Stromal Barriers to Augment Drug Penetration for Improved Cancer Therapy

Nanomedicine in Lung Cancer: Current States of Overcoming Drug Resistance and Improving Cancer Immunotherapy

Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment

Nanotechnology: A New Strategy for Lung Cancer Treatment Targeting Pro-Tumor Neutrophils

Strategies of targeting pathological stroma for enhanced antitumor therapies

Stromal Barriers and Strategies for the Delivery of Nanomedicine to Desmoplastic Tumors

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

Nanomaterials in tumor immunotherapy: new strategies and challenges

Exploring the tumor microenvironment with nanoparticles.

Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy

Enhanced nanoparticle delivery exploiting tumour-responsive formulations

Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery

Empowering lung cancer treatment: Harnessing the potential of natural phytoconstituent‐loaded nanoparticles